Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Beverly Green and William Vollmer.
Connection Strength

1.187
  1. Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models. Cancer. 2022 Jan 15; 128(2):410-418.
    View in: PubMed
    Score: 0.200
  2. Challenges in assessing population reach in a pragmatic trial. Prev Med Rep. 2019 Sep; 15:100910.
    View in: PubMed
    Score: 0.170
  3. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial. JAMA Intern Med. 2018 Sep 01; 178(9):1174-1181.
    View in: PubMed
    Score: 0.162
  4. Analytic Challenges Arising from the STOP CRC Trial: Pragmatic Solutions for Pragmatic Problems. EGEMS (Wash DC). 2015; 3(1):1200.
    View in: PubMed
    Score: 0.134
  5. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
    View in: PubMed
    Score: 0.121
  6. Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes. BMC Cancer. 2014 Feb 26; 14:55.
    View in: PubMed
    Score: 0.118
  7. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial. Trials. 2020 Jan 15; 21(1):91.
    View in: PubMed
    Score: 0.044
  8. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study. Cancer. 2020 02 01; 126(3):540-548.
    View in: PubMed
    Score: 0.044
  9. Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer. J Gen Intern Med. 2019 Jan 25.
    View in: PubMed
    Score: 0.042
  10. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Med. 2018 Sep; 7(9):4781-4790.
    View in: PubMed
    Score: 0.040
  11. Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health. 2018 02; 43(1):128-136.
    View in: PubMed
    Score: 0.039
  12. Data Sharing and Embedded Research. Ann Intern Med. 2017 11 07; 167(9):668-670.
    View in: PubMed
    Score: 0.038
  13. The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Fam Pract. 2016 12; 33(6):639-643.
    View in: PubMed
    Score: 0.035

© 2024 Kaiser Permanente